Impact of Modern Systemic Therapies on Survival in Patients with Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Review
In this single-institution cohort of 28 patients with ATC, patients who received either targeted therapies or immunotherapy demonstrated markedly improved outcomes. Further clinical trials are required to determine the optimal systemic therapy for this patient population.
Authors
- Jacob Thomas (ORCID: https://orcid.org/0000-0002-8420-366X)
- Qi Nie
- Robert C. Hsu (ORCID: https://orcid.org/0000-0003-3957-6106)
- Lydia D. Chow
- Trevor E. Angell (ORCID: https://orcid.org/0000-0002-9929-0188)
- Darin Poei
- Austin Luong
- Ming Li (ORCID: https://orcid.org/0000-0001-6986-6425)
- Liyang Tang (ORCID: https://orcid.org/0000-0002-4639-3925)
Institutions
- University of Southern California (US)
- USC Norris Comprehensive Cancer Center (US)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1007/s40801-025-00493-y
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00